Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer

摘要：

Interleukin-6(IL-6) is involved in lung cancer tumorigenesis,tumor progression,metastasis,and drug resistance.Previous studies show that blockade of IL-6 signaling can inhibit tumor growth and increase drug sensitivity in mouse models.

作者: Yanxiao Wang

作者单位: State Key Laboratory of Proteomics,Genetic Laboratory of Development and Diseases,Institute of Biotechnology,Beijing,China

会议类型: 国内会议

会议名称: 2016第四届“模式生物与人类健康”发育遗传学峰会

会议地点: 上海

会议语种:英文

页码: 87-87

在线出版日期: 2016-04-07（万方平台首次上网日期，不代表论文的发表时间）